IndraLab

Statements


JOSD2 leads to the acetylation of PKM2 on K433. 1 / 1
| 1

reach
"JOSD2 inhibits nuclear localisation by reducing the lysine 433 acetylation of PKM2 in acute myeloid leukaemia (AML), thereby decreasing downstream gene expression and ultimately slowing AML progression."